What is RadMD?
RadMD operates as an expertise-based image management service organization, offering consulting, training, and independent imaging services tailored for the pharmaceutical, biotechnology, and medical device sectors. The company has a proven track record, having designed and executed imaging endpoints for over 600 studies and performed comprehensive image reviews and analysis. Furthermore, RadMD has successfully trained more than 1,000 sites to enhance their image assessment capabilities, solidifying its role as a critical partner in clinical research and development.
How much funding has RadMD raised?
RadMD has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in RadMD
PPP
Public-Private Partnership
What's next for RadMD?
With substantial late-stage funding and a recent strategic investment, RadMD is poised for significant growth and market penetration. The company's focus on optimizing image assessment within the life sciences industry, coupled with its extensive experience, positions it to capitalize on the increasing demand for high-quality, reliable imaging data in drug development and medical device trials. Future initiatives are likely to involve scaling its service offerings, expanding its technological infrastructure, and forging deeper partnerships within the pharmaceutical and biotechnology ecosystems.
See full RadMD company page
